dotMD.com
Depression, Bipolar & Mood Disorders • ICD-10-CM F30.0

Anabolic Steroids

Also known as: Anabolic-androgenic steroids

Audited by the DotMD AI Specialist Council • FDA DailyMed SPL: 2026-11-02 • ICD-10-CM F30.0 • 8 Linked .gov / PubMed Citations • Governance: Dr. Hannah Lindqvist, MD, PhD (NPI #1457952647)
Methodology & AI Transparency ⓘ
Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.
At a Glance • Plain-English Clinical Summary

Anabolic Steroids Key Takeaways

Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about Anabolic Steroids

3 of 3 Free Questions Remaining

What Is Anabolic Steroids?

What are anabolic steroids? Anabolic steroids are synthetic (man-made) versions of testosterone. Testosterone is the main sex hormone in men. It is needed to develop and maintain male sex characteristics, such as facial hair, deep voice, and muscle growth. Women do have some testosterone in their bodies, but in much smaller amounts. What are anabolic steroids used for? Health care providers use anabolic steroids to treat some hormone problems in men, delayed puberty , and muscle loss from some diseases. But some people misuse anabolic steroids by taking them in a way that's different than their provider prescribed.

Pathophysiology, Underlying Causes & Clinical Presentation

Tissue-level etiology in Anabolic Steroids (F30.0) features dopamine) signaling imbalance [Anabolic Steroids F30.0]. Cross-referenced with NIH MeSH (Anabolic Agents), therapeutic stabilization in depression & mood is verified against Serum Vitamin D in Anabolic Steroids (F30.0: & RBC Folate).

Common Symptoms & Clinical Signs

  • • Stunted growth in teens
  • • High blood pressure
  • • Presentation of Anabolic Steroids (F30.0): disrupted sleep architecture [Anabolic Steroids F30.0]
  • • Secondary Anabolic Steroids clinical sign: slowed concentration, indecisiveness, in Anabolic Steroids (F30.0: and physical heaviness)

Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗

Anabolic Steroids Diagnostic Classification & Lab Markers

Metric Verified Benchmark Source
ICD-10-CM Diagnostic Code F30.0 WHO / CMS ICD-10-CM Clinical Classification
Clinical Specialty Hub Depression, Bipolar & Mood Disorders NIH MedlinePlus Health Topics
Diagnostic / Lab Marker: TSH & Free in Anabolic Steroids (F30.0: T4 Rule-Out) TSH 0.8 – 2.5 mIU/L (F30.0) Clinical Reference Target Range
Diagnostic / Lab Marker: Serum Vitamin D in Anabolic Steroids (F30.0: & RBC Folate) 25(OH)D 40 – 65 ng/mL (F30.0) Clinical Reference Target Range
Diagnostic / Lab Marker: PHQ-9 Symptom Severity in Anabolic Steroids (F30.0: Score) < 4 (clinical remission) (F30.0) Clinical Reference Target Range
Marcus Sterling (AI Healthcare Price Auditor) & Dr. Vance

FDA-Monographed Medications & Public Cash Price Reference for Anabolic Steroids

Check Drug Interactions →

Treatment selection for Anabolic Steroids depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.

Dr. Lin (AI PubMed Clinical Trial Lead)

Peer-Reviewed Human Clinical Trials & Meta-Analyses (Anabolic Steroids)

Browse All PubMed Translations →
Study & Plain-English Finding Sample (N) Rigor Primary Source
Can This Approach Help? Inside the Latest Research on Sertraline in children and adolescents with

In the gold-standard blind studies, children and adolescents had different patterns of response with sertraline vs.

Journal of the American Academy of Child and Adolescent Psychiatry • 2006-10-15 • Randomized Controlled Trial
N = 177 88/100 PMID 17003661 ↗
Can This Approach Help? Inside the Latest Research on Whole blood BDNF is lower in patients with depression and unchanged by

Wb-BDNF reflects the total blood BDNF pool and avoids platelet aggregation-related confounds seen in s-BDNF measures.

Progress in neuro-psychopharmacology & biological psychiatry • 2025-08-30 • Randomized Controlled Trial
Multi-cohort 88/100 PMID 40816605 ↗
Managing Resistant depression: Can Topiramate augmentation Make a Real Difference? (What New Research Reveals)

Our gold-standard blind compared against a dummy pill (placebo) study demonstrated that topiramate augmentation potentiate the efficacy of selective serotonin reuptake inhibitors (SSRIs) in treatment of resistant depression.

Progress in neuro-psychopharmacology & biological psychiatry • 2011-06-01 • Randomized Controlled Trial
Multi-cohort 88/100 PMID 21291943 ↗
Can This Approach Help? Inside the Latest Research on Combination of pharmacotherapy with electroconvulsive therapy in prevention of

Comparative efficacy of c-pharm early and late strategies in providing improved protection against post-ECT relapse of depression needs to be further explored.

The journal of ECT • 2010-06-15 • Randomized Controlled Trial
Multi-cohort 88/100 PMID 19935091 ↗
What the Latest Evidence Really Says About Anabolic Androgenic Steroids on the Reproductive System of Athletes and

The majority of AAS users demonstrated hypogonadism with persistently low gonadotropin and testosterone levels, lasting for several weeks to months after AAS withdrawal.

Sports medicine (Auckland, N.Z.) • 2017-09-15 • Meta-Analysis
N = 65 86/100 PMID 28258581 ↗
Zero-PHI Patient Support & Cohort Discussions

Anabolic Steroids Patient Community & “People Like Me” Threads

“People Like Me” Cohort Filter (Zero-PHI)

Filter Anabolic Steroids community threads and patient logs by age, biological sex, dosage, and treatment duration.

Female • 45-59 • Biomarker: TSH & Free in Anabolic Ste • Week 2928 helpful • 2 replies

Tracking TSH & Free in Anabolic Steroids (F30.0: T4 Rule-Out) every 12 weeks for Anabolic Steroids: what lab cadence worked best?

Pinned FDA/PubMed Clinical Context Note • Dr. Lin — AI PubMed Clinical Trial Lead

FDA/PubMed Clinical Context Note: Clinical guidelines across Depression, Bipolar & Mood Disorders (Anabolic Steroids, ICD-10-CM F30.0) generally pair 8-to-12-week repeat biomarker verification (TSH & Free in Anabolic Steroids (F30.0: T4 Rule-Out): TSH 0.8 – 2.5 mIU/L (F30.0)) with symptom review so steady-state physiological response is captured accurately.

After being diagnosed with Anabolic Steroids (ICD-10 F30.0), my clinician and I set a goal around TSH & Free in Anabolic Steroids (F30.0: T4 Rule-Out) (TSH 0.8 – 2.5 mIU/L (F30.0)) before escalating medication doses. For others managing depression & mood markers, did quarterly bloodwork catch changes early enough without over-testing?

Male • 30-44 • Week 24

12-week intervals worked really well for tracking TSH & Free in Anabolic Steroids (F30.0: T4 Rule-Out). Using the same morning fasting draw window each quarter eliminated day-to-day noise so my doctor could adjust cleanly.

Adult • 45-59 • Direct Lab Cash

Ordering TSH & Free in Anabolic Steroids (F30.0: T4 Rule-Out) alongside standard preventive labs prior to my follow-up visit saved an extra co-pay and kept our appointment focused on actual trend lines.

Related Conditions in Depression, Bipolar & Mood Disorders